AgeX Therapeutics Licensee ImStem Biotechnology Announces FDA Lifted the Hold and Cleared the Investigational New Drug Application for IMS001 for the Treatment of Multiple...
IMS001 was derived from the pluripotential cell line designated ESI-053 licensed from AgeX Therapeutics.
FDA Provides Guidance on Production of Alcohol-Based Hand Sanitizer to Help Boost Supply, Protect the Public
FDA notes these guidance documents will be in effect for the duration of the public health emergency declared by the Secretary of Health and Human Services (HHS) on January 31, 2020.
Feinstein Institutes Begins Enrolling Patients in Multiple COVID-19 Clinical Trials
In an effort to treat patients currently suffering from COVID-19, researchers from Feinstein Institutes are collaborating on new clinical studies with biopharmaceutical leaders Gilead Sciences, Regeneron and Sanofi.
Aperiomics Launches Xplore-COVID-19 Test for Novel Coronavirus
Aperiomics' Xplore-COVID-19 test is available nationwide today and the company has already begun taking orders for the test.
TransformativeMed Offering a COVID-19/Core Work Manager App to Seattle-Area Hospitals/Medical Centers Free of Charge During the COVID-19 Outbreak
COVID-19/CORES is already being used at UW Medicine, which includes the University of Washington Medical Center and Harborview Medical Center.